SuperX
  1. Home
  2. Stocks
  3. LIVEN
  4. News and notes

LIVEN · PHARMACEUTICALS

LIVEN news and notes Liven Pharma Limited

Liven Pharma Limited (LIVEN) news and notes: the SuperX note and what changed (3 items). The note is written by SuperX’s AI from its own figures. What changed is listed newest first.

What SuperX wrote about LIVEN

  1. No filing, story or sector move explains it. The price rose 9.99% on 20 Nov.

  2. The volume was 3.53 million shares, 5.74 times the usual volume. Only 9 of 248 sessions moved as far.

  3. Latest results show EPS of -0.07, against -0.28 a year ago. The price fell 6 times after results since 17 Mar 2025.

Written by SuperX’s analyst desk from SuperX’s own figures, from the close of 20 Nov 2026. Each number was checked against those figures. Not advice.

What changed for LIVEN, newest first

  • 20 Nov 2026Closed 52.40, +9.99%. Volume 3.53 m, 11.2 times the average of the 30 sessions before it, 315,586.
  • 17 Nov 2026Trend read changed to leaning up: above the 50-day average; up 54.9% over 3 months; fell 53.4% from its 1-year peak at worst.
  • 2 Nov 2026Results filed on 2 Nov 2026; the figures are not stored yet.

As of the close of 20 Nov 2026. Closes and notices: PSX. Trend read: SuperX, from daily closes. Volume: against the average of the 30 sessions before the last. Not advice.

More on LIVEN

Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .